• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives

    2022-06-29 01:46:54LieZhengYongYiJiXinLiWenShengLeiDuan
    World Journal of Gastroenterology 2022年23期

    Lie Zheng, Yong-Yi Ji, Xin-Li Wen, Sheng-Lei Duan

    Abstract With the development of microbiology and metabolomics, the relationship between the intestinal microbiome and intestinal diseases has been revealed. Fecal microbiota transplantation (FMT), as a new treatment method, can affect the course of many chronic diseases such as metabolic syndrome, malignant tumor,autoimmune disease and nervous system disease. Although the mechanism of action of FMT is now well understood, there is some controversy in metabolic diseases, so its clinical application may be limited. Microflora transplantation is recommended by clinical medical guidelines and consensus for the treatment of recurrent or refractory Clostridium difficile infection, and has been gradually promoted for the treatment of other intestinal and extraintestinal diseases.However, the initial results are varied, suggesting that the heterogeneity of the donor stools may affect the efficacy of FMT. The success of FMT depends on the microbial diversity and composition of donor feces. Therefore, clinical trials may fail due to the selection of ineffective donors, and not to faulty indication selection for FMT. A new understanding is that FMT not only improves insulin sensitivity,but may also alter the natural course of type 1 diabetes by modulating autoimmunity. In this review, we focus on the main mechanisms and deficiencies of FMT, and explore the optimal design of FMT research, especially in the field of cardiometabolic diseases.

    Key Words: Fecal microbiota transplantation; Metabolic diseases; Inflammatory bowel disease; Type 1 diabetes; Metabolic syndrome

    INTRODUCTION

    Most of the research on microorganisms is confined to infectious diseases and the role of microorganisms in human health is largely ignored. The average weight of these microorganisms is about 1.5 kg, equivalent to the weight of the liver. There are 1012-1014microorganisms, which is 10 times the number of the human body’s own cells, and they are mainly parasitic in the intestinal tract[1]. These symbiotic microorganisms include bacteria, viruses, archaea, fungi and, in some cases, protists,collectively known as the microbiome. The most important advantage of fecal microbiota transplantation (FMT) is the determination of cause and effect of disease through microbiology[2] .

    During the long process of human evolution, the intestinal flora has coevolved with its host, along with social development, changes in diet, lifestyle and environment. Intestinal symbiotic bacteria can regulate a variety of metabolic activities that cannot be carried out by the human body itself[3]. They can obtain energy by decomposing polysaccharides, proteins and fats in food that cannot be fully digested by the host, and produce a series of metabolites that affect the health of the host. In this process, the intestinal microecosystem is closely related to the host metabolic capacity[4].

    As early as 3000 years ago, cow dung was used in India to treat gastrointestinal diseases. As early as the Eastern Jin Dynasty (317-420 AD), a treatment similar to fecal bacterial transplantation, called“Huanglong Soup”, was described in Ge Hong’s “Urgent Prescription for Elbow Reserve”, which was used to treat food poisoning and diarrhea. In traditional Chinese medicine, it is recorded that huanglian and rhubarb, among others, have the curative effect of “quenching thirst” (ancient term for diabetes).Berberine, a monomer component from huanglian, has been recognized internationally for its effect on improving glucose and lipid metabolism earlier. During World War II, German soldiers in North Africa treated diarrhea with camel excrement[5]. At present, FMT is mainly used for the treatment of recurrentClostridium difficileinfection (CDI) in clinical practice, and many clinical trials have confirmed that FMT is a feasible treatment[6].

    At present, with the development of fast and accurate high-throughput sequencing technology and the improvement of bioinformatics technology methods, intestinal flora is closely related to metabolic syndrome (MS), type 1 diabetes (T1D) and type 2 diabetes (T2D), various cancers, and autoimmune diseases. Currently, it is believed that the FMT donor should be carefully selected and examined for infectious diseases[7]. However, due to the large difference in metabolism and diet of FMT donors, the effect of transplantation can be different. In this review, the mechanisms and deficiencies of FMT are discussed, and the optimal design of FMT is explored to maximize scientific research and clinical application methods.

    COMPOSITION AND METHOD OF FMT

    The main components of FMT are the gut flora of humans and other species. Humans have evolved to come into contact with a variety of bacteria, including those produced by food fermentation. The oral cavity is an important location of intestinal microbiota, which has an important effect on human health.Studies have shown that children who grow up on farms have a lower risk of asthma; a phenomenon that may be linked to changes in their gut microbiota[8]. In addition, babies born by cesarean section are at increased risk of developing autoimmune diseases, mainly because the initial microbes passed from the vagina to the baby at birth are replaced by skin microbes from the mother and surgical team members, which alter the baby’s gut microbes[9]. An infant’s gut microbiome can be reshaped in breast milk by adding small amounts of bacteria from the mother’s feces, creating a pattern that more closely resembles that of babies born vaginally[10].

    FMT has been processed into an odorless and tasteless preparation. In clinical practice, there are three methods of bacterial flora transplantation for patients willing to accept FMT: Upper, middle and lower digestive tract. The methods of transplanting upper digestive tract microflora mainly include oral microflora liquid and oral microflora capsule. The middle digestive tract approach includes a nasointestinal tube, endoscopic biopsy hole, percutaneous endoscopic gastrostomy and jejunal catheterization, endoscopic catheterization such as Transendoscopic enteral tubing (TET)[11]. The lower gastrointestinal pathway includes colonoscopy, colostomy, enema, and colonic pathway TET. Colonic pathway TET is not only used for microflora transplantation, but also for whole colon administration such as mesalazine, hormones and traditional Chinese medicine. As a new endoscopic technique, TET is an important supplement for interventional treatment of inflammatory bowel disease[12].

    FMT focuses on flora transplantation, but other components, such as phages, should not be ignored,which may be the reason for FMT’s effectiveness in the treatment of recurrent CDI. Therefore, phage research is important, and animal studies have shown that fecal virus transplantation also plays an important role. Analysis of the feces of adults on a classic British diet found that 25% of the 100 g/d excreted was made up of bacteria and 75% of fiber, protein, fat, bile acids and short-chain fatty acids(SCFAs). In most FMT, however, feces are simply mixed with salt water and filtered to remove insoluble substances[13]. Thus, the potential effects of FMT may be partly due to the combined effects of these compounds (Figure 1).

    AUTOLOGOUS FMT

    Most studies have focused on fecal transplants from healthy donors (known as FMT allografts).However, autologous fecal transplants have significant advantages[14], such as reducing the risk of infection and increasing the efficiency of transplantation, especially in the treatment of recurrent CDI by freezing their own feces. Autologous fecal transplants are effective in many diseases, but not in disorders caused by intestinal flora disorders, such as inflammatory bowel disease[15]. Studies have shown that disorder of intestinal flora can aggravate the disease, and intestinal inflammation can also affect the composition of intestinal flora[16]. Therefore, it is speculated that fecal biobanks may contain probiotics, which have changed the composition of intestinal flora before the relapse of the disease. This requires further confirmation of the value of probiotics in intestinal flora, but there is insufficient evidence to confirm the value of probiotics collected in clinical remission. Therefore, autologous FMT can improve clinical symptoms by regulating intestinal flora to promote metabolism[17].

    In conclusion, regulating the balance of intestinal flora is the primary goal of therapy. Autologous FMT through a duodenal tube or oral capsules can reshape the composition of small intestinal flora,which play an important role in the regulation of autoimmune diseases[18], mainly because the immune system response to antigenic stimuli occurs in the small intestine. It has also been suggested that autologous FMTviathe duodenal tube may be valuable in a new method of preserving β-cell function for T1D diagnosis that is more effective than healthy donor FMT[19].

    FMT AND METABOLIC DISEASES

    MS

    To date, the only reported study of FMT in the treatment of human MS was conducted by Witkowskiet al[20]. This study examined the effects of FMT on glucose and lipid metabolism in men with MS in a double-blind randomized controlled trial in nine patients receiving fecal bacteria transplants from lean healthy donors (allograft group) and nine other patients[21]. They received their own fecal bacteria as a control (autologous transplantation group)[22]. After 6 wk of FMT treatment, insulin sensitivity and fecal microbial diversity were significantly increased in the allograft group, while no significant changes were observed in the autograft group. It should be noted that there were individual differences in the efficacy of FMT[23], and Gagliardiet al[24] suggested that the differences might have been more due to different donors than recipients, since the two subjects receiving fecal bacteria from the same donor showed similar benefits[24]. In a randomized, double-blind, controlled trial of fecal bacteria transplantation in patients with MS it was found that insulin sensitivity and butyric acid-producing intestinal flora significantly improved in patients receiving fecal donation[25]. FMT strengthened the intestinal barrier function and effectively reduced endotoxemia in a nutritionally obese rat model. It is also concluded that FMT can regulate the lipid content of obese rats and reduce hepatic steatosis[26]. There are currently four clinical trials of FMT for MS registered with clinicaltrials.gov. We believe that the results of these clinical trials can provide us with a better understanding of the role of intestinal flora in human metabolic disorders[27].

    T1D

    Figure 1 Components that are transferred during fecal transplantation.

    There is a close relationship between intestinal flora and diabetes mellitus. Some studies have found that the decrease of butyrate- and lactate-producing bacteria is related to the autoimmunity of β cells[28]. In addition, it has been found that the intestinal flora of children with β-cell-related autoimmune diseases lacksBifidobacterium, and the bacteria producing butyrate and lactate are reduced while Bacteroidetes are increased[24]. Another study in Spain found similar changes in the gut flora of children with T1D, suggesting that structural changes in the gut flora may be associated with T1D[29]. A meta-genomic analysis of the intestinal flora in an included study found that, compared with the control group, patients with T1D had fewer butyrate-producing bacteria and mucin-degradingPrevotellaandAkkermansia, and had more lactate-producing bacteria, and bacteria-producing SCFA other than butyrate, such asBacteroidesandRiyanella[30].All of these suggest that gut bacteria may participate in the disorder of immune function in patients with T1D[31].

    Dietary fiber can be metabolized and fermented by intestinal bacteria into SCFAs, including acetic acid, propionic acid and butyric acid, which may also be involved in the pathogenesis of metabolic diseases[32]. The types and quantities of SCFAs are thought to vary with the composition of intestinal microbes. In addition to serving as an energy source for intestinal epithelial cells and liver (SCFAs are absorbed by the intestine and transported mainly through the portal vein), SCFAs are thought to have immunomodulatory effects by reducing intestinal permeability[33]. Lipopolysaccharides from intestinal translocation to the portal vein are thought to be involved in obesity-related mild inflammatory responses and insulin resistance in mice[34].

    SCFAs produce a small number of microorganisms in T1D, and the incidence of T1D is significantly reduced in nonobese diabetic mice treated withAkkermansiaor with a prebiotic diet supplemented with SCFAs[35]. It has been suggested that the restoration of intestinal flora balance through healthy donor FMT may further weaken autoimmune function and β-cell dysfunction[36]. A recent study showed that both healthy autologous and allogeneic FMT attenuates the decline of β-cell function, while donor FMT decreases at a slower rate[37]. Surprisingly, the decay rate of autologous FMT b cells was only 12 mo after three consecutive FMT treatments. Due to the significant changes in microbes from the mouth to the anus during autologous FMT[38], the immune system of the small intestine can be reshaped. Due to the lack of effective immunomodulators to treat T1D, a large number of clinical studies are needed to confirm this[39].

    T2D

    The association between intestinal flora and T2D was first reported by Chinese researchers led by The Shenzhen Huada Institute for Life Sciences and published in Nature in 2012[40]. This study found that the relative abundance of clostridium butyricum and its butyric acid-producing function in Chinese patients with T2D were significantly lower than those in the normal population, and lipopolysaccharide produced by conditional pathogenic Enterobacteriaceae species, hydrogen sulfide proinflammatory function and branched chain amino acid transport function levels were significantly higher than the general population[41]. These changes may be associated with impaired intestinal mucosal barrier function and increased levels of intestinal inflammation in T2D patients[42].

    A randomized controlled study showed that autologous FMT can maintain normal metabolism after diet-induced weight loss[43]. It has been observed that obese donor FMT can cause rapid weight gain,so there is a link between the intestinal microbiome, obesity and insulin resistance[44]. On the contrary,non-obese donor FMT can improve insulin resistance in obese patients with MS. Another study found that donor FMT had no effect on glucose metabolism and their diets were metabolically tested. Recent studies have shown that the use of single-dose capsule FMT improves lipid metabolism and insulin resistance, mainly through continuous supplementation of low-fermenter fiber[45]. Therefore, dietary composition may affect insulin resistance of FMT, or metabolites of donor FMT may affect the enteric-brain axis[46].

    NONALCOHOLIC FAATTY LIVER DISEASE

    The relationship between intestinal microflora and nonalcoholic faatty liver disease (NAFLD) is increasingly close, research suggests. Intestinal flora can affect the occurrence and development of NAFLD by changing the composition of intestinal flora, increasing serum endotoxin level and intestinal permeability, producing endogenous alcohol and changing choline metabolism[47]. Animal studies have shown that FMT can improve steatohepatitis in mice induced by high-fat diet, reduce the production of lipids and proinflammatory factors in the liver, regulate the balance of intestinal flora in mice, and increase the abundance of beneficial flora[48]. After FMT treatment, the cecal butyrate concentration and intestinal tight junction protein ZO-1 increased, and the toxin release decreased, thus reducing the inflammatory response[49].

    Increased intestinal permeability and metabolic endotoxin caused by changes in intestinal flora composition are involved in the progression of NAFLD in mice, and the severity of NAFLD in mice is increased when special flora are transferred to methionine- and choline-deficient diet, indicating that intestinal flora is involved in the progression of NAFLD[50]. The results of human studies also support the idea that changes in gut flora can contribute to fatty liver disease. Compared with normal subjects,NAFLD patients showed increased intestinal permeability, endotoxemia, increased numbers of g-Proteobacteria, and decreased numbers of Bacteroidetes[51].

    Fatty liver often occurs in obese patients. Long-term vegans have a lower risk of NAFLD, which may be related to changes in gut flora. It is suggested that FMT treatment of long-term vegan feces can improve liver inflammation score[52]. Despite the small sample size, this study still found that the inflammatory necrotic tissue score and inflammatory gene expression were reduced after transplantation of vegan fecal flora, which may be an important indicator for predicting the progression of NAFLD to cirrhosis[53]. At the same time, an FMT study in NAFLD patients showed that healthy donor FMT reduced intestinal permeability, which is an important feature that distinguishes NAFLD from other diseases[48]. This study found that magnetic resonance imaging could not make a definitive diagnosis of hepatic adipose degeneration, which must be assessed using gold standard liver histological examination[54].

    PITFALLS

    Mode of delivery

    Since innate and adaptive immune cell reactions occur in the small intestine, immune diseases are usually treated by oral capsules or fresh feces administered through the duodenum under strict anaerobic conditions, in order to ensure that active aerobic and anaerobic bacteria can be transplanted to the maximum extent and thus reshape the intestinal microecological balance[55]. Remodeling of the small intestinal flora is not appropriate for nonimmune diseases or diseases with distal intestinal malformations, but colonic delivery (enema or colonoscopy) may be an option[56].

    Whether FMT plays an important role in other diseases besides recurrent CDI needs confirmation.Donor FMT freeze-drying capsules or frozen-solution capsules have been widely used and have gained more support due to their noninvasive administration[57], and it is also convenient for the donor and recipient to make multiple trips to the hospital for transplantation on the same day[58]. Current treatments for CDI include enemas, frozen capsules or freeze-drying formulations. However, it may not be suitable for mild intestinal microecological disorders that do not comply with GMP regulations as compared to fresh feces[59].

    PREPARATION OF FMT FECAL BACTERIA LIQUID

    Due to the lack of sufficient sample size and establishment of control groups in most clinical studies[55], the conclusions are not reliable, and there is controversy about the preparation of FMT fecal bacteria solution. (1) Selection of stool dilution materials[60]. It is reported that ordinary water (98.5%)has a higher disease remission rate than normal saline (86%) as a stool dilution material, but the recurrence rate of CDI with the former increased > 2 times. Other thinners, such as milk or salt water from plantain, achieved a 94% remission rate; (2) The amount of fecal bacteria liquid transplanted.When the volume of fecal bacteria liquid transplanted is > 500 mL, the remission rate of CDI is 97%, but< 200 mL, the remission rate is only 80%. However, it is difficult to compare the above conclusions because the dilution ratio of feces may vary. Currently, according to the Amsterdam protocol, 200-300 g of donor stool is dissolved in 500 mL normal saline for use (donor stool is preferably fresh within 6 h);and (3) Feasibility of frozen feces. A case report of standardized frozen stool samples used for fecal bacteria transplantation for the treatment of CDI showed that there was no statistical difference in the efficacy of standardized frozen stool compared with fresh stool. Therefore, establishment of stool donation banks and use of standardized frozen stool made fecal bacteria transplantation more feasible in clinical practice[61]. A recent study on the treatment of CDI by oral frozen fecal bacteria capsules showed that no serious adverse reactions occurred in recurrent CDI treated by fecal bacteria transplantationviaoral frozen fecal bacteria capsules[62]. The diarrhea relief rate of single administration was 70% (14/20), while four of six patients who did not respond to treatment achieved remission after second administration, resulting in a total remission rate of 90%. This study initially demonstrated the feasibility and safety of fecal bacteria transplantationviafrozen fecal bacteria capsules[63].

    THE PROCESSING OF FMT

    Protective measures are usually taken to avoid anaerobic bacteria being killed by coming in contact with oxygen[64], but it cannot be completely avoided. Under strict anaerobic conditions, the composition of diluted or filtered microorganisms does not differ significantly before and after the entire procedure, but the activity of the preparation may have been affected[65]. Similarly, prolonged freezing at -80 °C preserved fecal components to a large extent, but whether it had an effect on fecal activity was unclear[66]. However, recent studies have shown that autologous FMT stored in glycerin at -80 °C can completely restore the intestinal lumen and mucosal microbial balance. Whether FMT regulates mild microbial disorders in these studies remains to be confirmed[67].

    DIVERSITY OF THE GUT MICROBIOME

    The diversity of intestinal flora increases with growth and development, and finally forms a complex and relatively stable microbial community at the age of 2-3 years, mainly including bacteria, fungi,viruses and protozoa[68]. There are > 1000 species of bacteria, most of which are obligate anaerobes,including Firmicutes, Bacteroides, Proteobacteria and Actinomycetes, among which Firmicutes and Bacteroides are dominant, accounting for > 90% of all intestinal bacteria[69].

    Gut microbiome composition is temporal and spatially specific. Neonatal bacteria from the birth canal colonize the intestine within a few hours after birth. The intestinal microbial composition of early vaginally delivered babies is similar to that of the mother’s vagina, while that of cesarean delivery babies is different[70]. A baby’s gut microbiota can reach the level of a healthy adult at about age 1 year.Most of the microorganisms in the human intestine colonize the colon[71], and the number is 1012cfu/mL. The microbial content of the jejunum, ileum and duodenum decreases successively, and there are 107, 104and 103cfu/mL, respectively. There are also differences in the types of microorganisms rich in each part. In addition, the composition of intestinal mucosa and fecal-associated microorganisms varies[72].

    Individuals in the same area may have different gut microbiota. The composition and diversity of intestinal microbiota may influence the therapeutic effect of donor FMT[73], or even insulin resistance.In the past few decades, with the westernization of China’s diet, intestinal microbial diversity has decreased. Preselection of donor FMT may be a feasible way to improve clinical outcomes based on the presence of a specific biological chain. Therefore, an important method to study FMT is to carefully study the baseline data of patients and the microbial composition after FMT[74]. By comparing the baseline data of the donor and the recipient and the microbial composition during a certain period of time, the number of microbes transplanted from the donor to the recipient can be calculated[75]. The most common method is fecal metagenomic sequencing, which identifies microbial species based on specific mononucleotide degeneration[76]. Sequencing techniques combined with bioinformatics analysis reveal the duration of similarity between donor and recipient strains, and how many of the transplanted microbes are likely to restore the original microbial composition[77].

    DONOR-ACCEPTOR COMBINATION

    FMT is thought to restore disturbed gut flora to a healthy state either by implanting a donor strain or by other donor-dependent traits, such as the amount of nonbacterial components[78]. However, not all donor gut microbiota are uniform, and comparison of gut microbiota from different donors suggests that microbial diversity and metabolites may be predictors of the success of FMT[79]. In some studies,donor microbiome and metabolomic characteristics may be associated with FMT treatment response.Therefore, the selection of appropriate donor feces is a key factor in the success of FMT[80]. However,few studies of FMT have considered the influence of the variation characteristics of the intestinal microbiome and metabolome of the donor on clinical efficacy[81].

    Current studies have confirmed that after FMT treatment, the intestinal flora diversity of the recipient is significantly increased and tends to be the flora characteristics of the donor[82]. Cases that respond to FMT treatment typically show higher microbial diversity. It has been confirmed that intestinal bacterial abundance in donors that respond to FMT is significantly higher than that in donors that do not respond[83].

    To date, donor selection methods in FMT studies have included the use of a single donor or the random selection of multiple donors from a group of screened eligible donors[84]. In 2019, Zhenget al[85] first proposed the concept of super donors and believed that the success of FMT depends on the donor[85]. However, the definition of super donor has not been established, and the clinical efficacy of donors before FMT treatment cannot be predictedv[86]. However, the failure of randomly selected single donors may be due to the selection of ineffective donors rather than the incorrect indication selection of FMT[87]. Therefore, an alternative approach is to expose each patient to multiple donors(multidonor transplants) to reduce the risk of receiving FMT from an invalid donor[88]. However, FMT is still in the clinical research stage. Single donors can provide clearer evidence for clinical studies, while multiple donors lead to false negatives or false positives in clinical studies, thus hindering the development of the FMT field and the development of new microbiome therapies[89].

    Studies have shown a surprising match between donor and recipient transplants and FMT[90]. The ability to secrete blood group antigens is associated with a reduction in gut microbial diversity, which in turn determines the likelihood of successful transplantation from nonsecreting blood group donors to secreting blood group receptors, which may also apply to human leukocyte antigens (HLAs)[91]. HLA haploidy is an important risk factor for autoimmune diseases such as T1D, and infants with HLA haploidy associated with an increased risk of T1D do form a unique microbiome[92]. What remains to be proven, however, is whether FMT can correct the high-risk microbiome associated with specific HLA haplotypes later in life[93]. In addition, it needs to be considered that intestinal immunoglobulinsecretion-binding bacteria and their components may contribute to the therapeutic effect of donor FMT[94].

    CONCOMITANT MEDICATION

    To facilitate colonization (also known as transplantation), the recipient’s gut is usually cleaned, most commonly by enemas, laxatives, or broad-spectrum antibiotics[95]. In patients with ulcerative colitis,antibiotic administration after FMT increases the risk of transplant failure, although there is evidence that antibiotic pretreatment improves the efficacy of FMT[96]. Previous studies have shown that antibiotics, metformin, berberine and other drugs can change the intestinal flora, thus affecting the state of the body[97]. A study of Finnish children aged 2-7 years found that macrolide use was associated with subsequent long-term changes in intestinal microbiota composition and metabolism: A decrease in Actinobacteria and an increase in Bacteroidetes and Proteobacteria, decreased biliary saline hydrolyase and increased resistance to macrolides[98]. It is associated with an increased risk of asthma and weight gain. The effect of penicillin on intestinal flora was weaker than that of macrolides[99]. In addition to antibiotics, many Chinese herbal extracts can alter the intestinal flora[100]. A study in Taiwan Chang Gyeong Hospital found that ganoderma lucidum extract can reduce the body weight of high-fat-diet mice, reduce inflammatory response and insulin resistance, reduce intestinal flora Firmicutes/Bacteroidetes ratio and endotoxin levels, maintain the integrity of the intestinal barrier and reduce endotoxemia. It has been found that both berberine and metformin can reverse the changes in intestinal flora in mice induced by high-fat diet and significantly reduce the diversity of intestinal flora.Proton pump inhibitors (PPIs) are among the top 10 drugs widely used worldwide, and studies have found that PPI use is associated with intestinal infections, particularly CDI[101]. PPI users had significantly increased intestinal flora ofEnterococcus,Streptococcus,Staphylococcusand opportunisticEscherichia coli[102]. In addition, cardiovascular drugs such as statins, antihypertensive drugs,antiplatelet aggregation drugs, as well as opioids and antidepressants can affect the composition of gut microbes[103]. As confounding factors such as gender and age have a great influence on these results,confounding factors should be minimized, and random number tables should be used to conduct random-grouping studies, because the reactions caused by these drugs may be caused by microbial disorders[104].

    CONCOMITANT LIFESTYLE AND DIET

    When a donor transplants microbes to a recipient, the difference in microbial composition between the two may be partly due to lifestyle differences between the donor and recipient[105]. If the recipient’s lifestyle does not change to that of the donor after FMT, then the effect on the recipient’s microbial makeup may disappear over time. People living in different continents and regions have their own unique dietary habits[106]. The diet of Europeans is rich in cheese, butter and other high-fat and highcalorie foods, while the diet of Africans is low in calories and high in dietary fiber[107]. Highthroughput sequencing comparing the intestinal microbiota of European children with that of rural children from Burkina Faso, a landlocked country in Western Africa, revealed significant differences between the two[108].Prevotellaand Xylos bacteria, which are associated with cellulose and xylan hydrolysis, were completely absent in the intestinal flora of European children on a high-calorie and high-fat diet, while the intestinal flora of African children on a low-calorie and high-fiber diet was rich in Bacteroidetes, especiallyPrevotellaand Xylos bacteria, while Firmicutes were relatively rare[109]. In addition, African children were found to have significantly more SCFAs in their intestines than European children had, and the abundance of Enterobacteriaceae (mainlyShigellaandE. coli) was found to be lower than that of European children[110]. These results suggest that the intestinal flora of African children has adapted to a diet rich in polysaccharides to ensure adequate energy intake from a fiber-rich diet and to reduce the incidence of intestinal inflammatory and infectious diseases[111]. The lack of dietary fiber in the diet of European children may be responsible for the loss of prevosiella and Xylos bacteria associated with cellulose and xylan hydrolysis[112]. Another study found that increased dietary fiber intake increased the diversity of the gut flora, as well asPrevotellaabundance[113].

    Numerous studies have shown that changes in diet determine microbial composition[114]. When autologous FMT is administered during a particular diet, the beneficial effects of the diet persist even if the diet is no longer continued[115]. Conversely, changes in an individual’s microbial composition also affect diet. A large number of studies have shown that dietary response to FMT may be related to changes in microbial composition[116]. Thus, FMT transplantation using a standardized diet during clinical interventions may be more effective because an important source of microbiome variation has been eliminated, but it has been overlooked in many studies[117].

    POTENTIAL MECHANISM OF ACTION

    Although the causal relationship between intestinal microbiota and disease is still unclear, it is sufficient to inspire researchers to implement strategies for disease management by regulating intestinal microbiota[118]. Dietary management, antibiotics, probiotics and other interventions can directly or indirectly enable the reconstruction of intestinal flora[119]. FMT is based on microbiota treatment, in which the isolated functional bacteria are transplanted into the patient to reconstruct intestinal flora and achieve a steady state of the gut microbes so as to attain the purpose of disease treatment[120]. The specific mechanism of FMT has not been clarified yet, and its complex mechanism cannot be replaced and explained by a single strain or single signal[121]. In 2007, the “Human Microbiome Project”, also known as the “Human second Genome Project”, became the cornerstone of human exploration and understanding of intestinal microbes[122]. With the in-depth study of intestinal flora, the causal relationship between intestinal microbes and diseases will become more clear, and the specific action mechanism of FMT will become more clear.

    FMT has made great progress in the treatment of recurrent CDI. However, due to infection and repeated use of antibiotics, the diversity of intestinal flora is low and the interactions between microorganisms are affected. Studies have shown that FMT with a healthy diversity of microbiome may increase microbial diversity levels to normal levels and enhance microbial interactions[123]. Recent studies have shown that microorganisms produced by biliary saltase may help improve the efficacy of FMT in the treatment of recurrent CDI, as the enzyme degrades taurocholic acid and effectively inhibitsC. difficile[124]. Other studies have shown that FMT treatment can cause some subsequent problems,such as the use of antibiotics to cause bacterial dysregulation, leading to non-C. difficile-dependent colitis recurrence, and thus requiring new FMT corrective treatment[125].

    Studies have shown that the most important source of fecal genes is prokaryotic viruses (phages)[126]. Phages are probably also the most overlooked in terms of FMT. Because diarrhea is partially relieved in patients with a small amount of microbial FMT during recurrent CDI, this suggests that phages may play an important role in maintaining host health by regulating gut microbiome composition and its phenotype[127]. Phages play an important role in gene expression of host bacteria and even determine their survival. Thus, FMT may function through donor phage regulation of the recipient flora. Currently, phage transplantation is done through aseptic filtration, which has the advantage of reducing bacterial infection. In addition, a large number of clinical studies are needed to show that phage transplantation has greater application value and potential in some diseases.

    The mechanism of action of FMT therapy may be realized through multiple pathways, which may vary according to the FMT condition. However, one of the important mechanisms may be altered microbial metabolite production. This may occur during transplantation or subsequently by newly colonized microorganisms. The effect of the production of large quantities of small molecules by microorganisms on the host needs to be further clarified[128]. The most significant is SCFA butyrate,produced mainly by fibrinolytic enzyme strains, which reduces intestinal permeability and provides nutrients to intestinal cells, producing epigenetic effects[129]. In addition, fibrinolytic enzyme strains has anti-inflammatory properties and can reduce the incidence of T1D in NOD mice[130]. Therefore,FMT may modulate immune activity through autoantigens. In addition, studies have shown reduced production of butyrate strains in T1D[131]. However, when T1D patients were given high concentrations of butyrate, no significant changes were detected in immune cells, and when T1D patients were given FMT, butyrate as an active regulator of protective b cells and immune cells was not detected by metabolomics[132]. As a result, the research impact of using noninvasive biomarkers for microbial metabolism has been largely underestimated[133]. This phenomenon may partly explain some of the differences between rodent and human studies. In addition, it should be made clear that interventional studies cannot completely exclude the potential mechanism of action of butyrate in T1D[134]. Therefore,it is a long and tortuous road to find meaningful microorganisms from clinical observational studies to improve clinical outcomes.

    APPLICAATION PROSPECT OF FMT IN CLINICAL RESEARCH

    FMT is a new theory and technology that has prospects in the treatment of intestinal microbiome disorders. However, the mechanism of action, ethical issues and effects of FMT are still controversial.The methodology of donor screening, the preparation and state of fecal bacteria solutions, and the approaches to transplantation are not uniform, and there are different reports on the safety and efficacy of FMT treatment[135]. In the future, more and higher-quality randomized controlled clinical trials should be carried out to address the above problems, so as to provide more adequate evidence-based medical evidence[136]. It is certain that with the deepening of scientific research, the mechanism of FMT will be gradually clarified; the intestinal microbial spectrum, microbial metabolites and their association with diseases will be more clear; and the FMT methodology will be more standardized[137]. Despite its limitations, FMT is currently one of the most important tools for studying the role of microorganisms in the pathogenesis of a range of chronic diseases. To improve the effectiveness of studies, further standardization of FMT should be carried out, such as dosage, transplantation method, and whether to use alternate pretreatment of fresh or frozen preparations[138]. In addition, accurate assessments and calculations are required to avoid type I errors in order to accurately assess efficacy. Of course, many meetings and forums are needed to reach consensus.

    CONCLUSION

    Donor FMT can restore intestinal microbial function and improve clinical outcomes. Therefore, the question in the future is whether the addition of specific strains of FMT to microbial-targeted therapies can help improve diet and drug therapy to improve human health. Therefore, in order to improve the clinical treatment of recurrent CDI, there is a need for more standardized FMT techniques. Rapid advances in untargeted molecules and bioinformatics have made it possible to analyze in detail the potential mechanisms of action of FMT. These results can identify important microorganisms and their metabolites, which may be used as probiotics, probiotics and epigenetic bacteria to enhance the therapeutic effect of FMT, or even replace FMT, for treatment of metabolic diseases.

    FOOTNOTES

    Author contributions:Zheng L, Ji YY and Duan SL reviewed the literature and prepared the manuscript, performed to the writing, revising of the manuscript; Zheng L and Wen XL contributed to design this work, and performed overall supervision; Zheng L wrote and revised the paper; all authors approved the final manuscript.

    Supported byShaanxi Province Natural Science Basic Research Program-General Project, No. 2019JM-580 and No.2021SF-314; Project of Shaanxi Administration of Traditional Chinese Medicine, No. 2019-ZZ-JC010; and Shaanxi Provincial Hospital of Traditional Chinese Medicine, No. 2018-04 and No. 2021-07.

    Conflict-of-interest statement:The authors declare that there are no conflicts of interest related to this study.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:China

    ORCID number:Lie Zheng 0000-0002-8243-3736; Yong-Yi Ji 0000-0003-2001-9916; Xin-Li Wen 0000-0001-5003-862X;Sheng-Lei Duan 0000-0002-4151-1718.

    S-Editor:Fan JR

    L-Editor:A

    P-Editor:Fan JR

    久9热在线精品视频| 亚洲熟妇中文字幕五十中出| 亚洲国产欧美人成| 国产精品久久视频播放| 亚洲第一电影网av| 赤兔流量卡办理| 又紧又爽又黄一区二区| 男女下面进入的视频免费午夜| 国产精品免费一区二区三区在线| 丰满乱子伦码专区| 啪啪无遮挡十八禁网站| 国产v大片淫在线免费观看| 国产色婷婷99| 我的老师免费观看完整版| 国产三级在线视频| 欧美性感艳星| 麻豆av噜噜一区二区三区| 成人综合一区亚洲| 欧美三级亚洲精品| 免费电影在线观看免费观看| 欧美xxxx黑人xx丫x性爽| 蜜桃亚洲精品一区二区三区| 欧美激情国产日韩精品一区| 久久久久久九九精品二区国产| 久久99热这里只有精品18| 校园人妻丝袜中文字幕| 国产单亲对白刺激| 国产探花极品一区二区| 一级a爱片免费观看的视频| 国产一区二区在线av高清观看| 春色校园在线视频观看| 日本一本二区三区精品| 国产老妇女一区| 婷婷色综合大香蕉| 亚洲av熟女| aaaaa片日本免费| 国产在线精品亚洲第一网站| 亚洲一区二区三区色噜噜| 亚洲av美国av| 久久天躁狠狠躁夜夜2o2o| 欧美丝袜亚洲另类 | 亚洲国产欧美人成| 午夜精品久久久久久毛片777| 亚洲在线自拍视频| 身体一侧抽搐| 有码 亚洲区| 欧美色视频一区免费| 午夜久久久久精精品| 一个人看的www免费观看视频| 国产 一区精品| 俄罗斯特黄特色一大片| 久久草成人影院| 亚洲无线观看免费| 91久久精品电影网| 九九热线精品视视频播放| 能在线免费观看的黄片| 亚洲精华国产精华液的使用体验 | 三级男女做爰猛烈吃奶摸视频| 亚洲精品日韩av片在线观看| 最近中文字幕高清免费大全6 | 亚洲电影在线观看av| 他把我摸到了高潮在线观看| 亚洲五月天丁香| 欧美日韩亚洲国产一区二区在线观看| 成年版毛片免费区| 国产精品久久久久久精品电影| 毛片一级片免费看久久久久 | 久久热精品热| 两个人的视频大全免费| 国产不卡一卡二| 偷拍熟女少妇极品色| 韩国av在线不卡| 看黄色毛片网站| 精品人妻偷拍中文字幕| 少妇裸体淫交视频免费看高清| 亚洲欧美激情综合另类| 熟妇人妻久久中文字幕3abv| 一区福利在线观看| 午夜福利视频1000在线观看| 日韩一区二区视频免费看| 永久网站在线| 九九热线精品视视频播放| 韩国av在线不卡| 欧美日韩国产亚洲二区| 深夜a级毛片| 精品免费久久久久久久清纯| 成年女人毛片免费观看观看9| 国产精品亚洲美女久久久| 亚洲自拍偷在线| 亚洲熟妇熟女久久| 无人区码免费观看不卡| 内射极品少妇av片p| 久久久久久九九精品二区国产| 欧美一区二区国产精品久久精品| 啦啦啦啦在线视频资源| 人妻制服诱惑在线中文字幕| 少妇丰满av| 狠狠狠狠99中文字幕| 女的被弄到高潮叫床怎么办 | 禁无遮挡网站| 尤物成人国产欧美一区二区三区| 一个人看视频在线观看www免费| 成人三级黄色视频| 国产一区二区在线av高清观看| 欧美xxxx性猛交bbbb| av专区在线播放| 久久久久久九九精品二区国产| 露出奶头的视频| 简卡轻食公司| 久久久精品大字幕| 亚洲av五月六月丁香网| 日本色播在线视频| 成人午夜高清在线视频| 一级av片app| 亚洲va日本ⅴa欧美va伊人久久| 日本色播在线视频| 欧美黑人巨大hd| 久久精品国产鲁丝片午夜精品 | 狂野欧美白嫩少妇大欣赏| 精品久久久久久久人妻蜜臀av| 亚洲av中文av极速乱 | 又黄又爽又免费观看的视频| 成人毛片a级毛片在线播放| 亚洲熟妇熟女久久| 国产欧美日韩一区二区精品| 成人一区二区视频在线观看| 又粗又爽又猛毛片免费看| 久久久久久国产a免费观看| 国产中年淑女户外野战色| 日韩欧美在线乱码| 2021天堂中文幕一二区在线观| 国产高清有码在线观看视频| 成人二区视频| 免费看光身美女| 少妇丰满av| 男插女下体视频免费在线播放| 大又大粗又爽又黄少妇毛片口| 一进一出抽搐gif免费好疼| a级毛片免费高清观看在线播放| 国产精品伦人一区二区| netflix在线观看网站| av国产免费在线观看| 99国产精品一区二区蜜桃av| 久久精品国产亚洲av天美| 国内精品美女久久久久久| 久久久久久国产a免费观看| 啦啦啦啦在线视频资源| .国产精品久久| 国产精品,欧美在线| 久久久国产成人免费| 真人做人爱边吃奶动态| av中文乱码字幕在线| 噜噜噜噜噜久久久久久91| 免费看日本二区| .国产精品久久| 国产国拍精品亚洲av在线观看| 夜夜夜夜夜久久久久| 一个人看的www免费观看视频| 国产高清视频在线观看网站| 午夜爱爱视频在线播放| 91狼人影院| 亚洲欧美日韩无卡精品| 岛国在线免费视频观看| 久久精品国产亚洲av天美| 精品一区二区三区人妻视频| 欧美性感艳星| 国内久久婷婷六月综合欲色啪| 免费观看在线日韩| 久久久精品欧美日韩精品| 欧美成人免费av一区二区三区| 精品福利观看| 变态另类丝袜制服| 非洲黑人性xxxx精品又粗又长| 欧美人与善性xxx| 在线观看一区二区三区| 18禁裸乳无遮挡免费网站照片| 成人一区二区视频在线观看| 亚洲欧美日韩无卡精品| 桃红色精品国产亚洲av| 看黄色毛片网站| 久久亚洲精品不卡| 性色avwww在线观看| 色综合婷婷激情| 18禁黄网站禁片免费观看直播| 国产亚洲av嫩草精品影院| a级一级毛片免费在线观看| 国产午夜精品久久久久久一区二区三区 | 在线观看免费视频日本深夜| 99热只有精品国产| av女优亚洲男人天堂| 中文字幕高清在线视频| 久久精品国产自在天天线| 好男人在线观看高清免费视频| netflix在线观看网站| 久久婷婷人人爽人人干人人爱| 国产欧美日韩一区二区精品| 日本熟妇午夜| 99热只有精品国产| 麻豆av噜噜一区二区三区| 99视频精品全部免费 在线| 女生性感内裤真人,穿戴方法视频| 欧美3d第一页| 欧美区成人在线视频| 亚洲av日韩精品久久久久久密| 免费黄网站久久成人精品| 欧美色欧美亚洲另类二区| 看十八女毛片水多多多| 亚洲av成人av| 成年免费大片在线观看| 又紧又爽又黄一区二区| 最近视频中文字幕2019在线8| 亚洲avbb在线观看| 精品人妻偷拍中文字幕| 欧美成人a在线观看| 男女那种视频在线观看| 此物有八面人人有两片| 亚洲七黄色美女视频| 日本在线视频免费播放| 日韩一本色道免费dvd| 女人十人毛片免费观看3o分钟| 日日夜夜操网爽| 国产精品久久久久久亚洲av鲁大| 一个人观看的视频www高清免费观看| 免费观看精品视频网站| 日日啪夜夜撸| 桃红色精品国产亚洲av| 欧美绝顶高潮抽搐喷水| 天堂√8在线中文| 欧美日韩亚洲国产一区二区在线观看| 老熟妇仑乱视频hdxx| 69人妻影院| 亚洲av成人精品一区久久| 搡老岳熟女国产| 亚洲最大成人手机在线| 伦精品一区二区三区| 久久久久久伊人网av| 很黄的视频免费| 夜夜看夜夜爽夜夜摸| 日韩欧美免费精品| 国产在视频线在精品| 国产三级中文精品| 最近最新免费中文字幕在线| 中文资源天堂在线| 国产精品一及| 色视频www国产| 国产视频一区二区在线看| 观看美女的网站| 九色国产91popny在线| 日韩一本色道免费dvd| 亚洲精品久久国产高清桃花| netflix在线观看网站| 亚洲av免费在线观看| 国产精品伦人一区二区| 22中文网久久字幕| 亚洲精品影视一区二区三区av| 看黄色毛片网站| 国产精品免费一区二区三区在线| 亚洲精品456在线播放app | 麻豆精品久久久久久蜜桃| 亚洲精品一卡2卡三卡4卡5卡| 91久久精品国产一区二区三区| 亚洲av电影不卡..在线观看| 大型黄色视频在线免费观看| 亚洲精品影视一区二区三区av| av在线亚洲专区| 99在线人妻在线中文字幕| 国产精品久久电影中文字幕| 日韩一本色道免费dvd| 国产成人影院久久av| 免费看光身美女| 色综合站精品国产| 久久久久精品国产欧美久久久| 精品人妻视频免费看| 禁无遮挡网站| 天堂av国产一区二区熟女人妻| 亚洲av二区三区四区| 99热这里只有是精品50| 老司机深夜福利视频在线观看| 国内精品美女久久久久久| 亚洲性夜色夜夜综合| 熟女人妻精品中文字幕| 成人欧美大片| 成年女人看的毛片在线观看| 国产欧美日韩精品亚洲av| videossex国产| 天堂网av新在线| 999久久久精品免费观看国产| 亚洲熟妇中文字幕五十中出| x7x7x7水蜜桃| av在线亚洲专区| 男女啪啪激烈高潮av片| 亚洲av.av天堂| 中亚洲国语对白在线视频| 久99久视频精品免费| 免费在线观看日本一区| 又粗又爽又猛毛片免费看| 亚洲七黄色美女视频| 真实男女啪啪啪动态图| 两个人的视频大全免费| 免费看美女性在线毛片视频| 午夜福利成人在线免费观看| 在线a可以看的网站| АⅤ资源中文在线天堂| 欧美色欧美亚洲另类二区| 日本黄色视频三级网站网址| 最近最新免费中文字幕在线| 国产精品乱码一区二三区的特点| 成人特级av手机在线观看| 99久久成人亚洲精品观看| 日本-黄色视频高清免费观看| 亚洲内射少妇av| 久久久色成人| 啦啦啦观看免费观看视频高清| 国产精品98久久久久久宅男小说| 男女边吃奶边做爰视频| 亚洲狠狠婷婷综合久久图片| 成年免费大片在线观看| 亚洲欧美日韩东京热| 午夜福利欧美成人| 欧美在线一区亚洲| 又爽又黄a免费视频| 男女啪啪激烈高潮av片| 91久久精品国产一区二区成人| 精品一区二区三区av网在线观看| 又粗又爽又猛毛片免费看| 成人午夜高清在线视频| 精品久久久久久久久久久久久| 日韩一本色道免费dvd| 免费人成视频x8x8入口观看| 老师上课跳d突然被开到最大视频| 成人av一区二区三区在线看| 亚洲精品国产成人久久av| 男人狂女人下面高潮的视频| 国产精品一区二区性色av| 少妇裸体淫交视频免费看高清| 又爽又黄a免费视频| 日韩一本色道免费dvd| 亚洲国产精品成人综合色| 日韩欧美国产在线观看| 男人舔奶头视频| 免费观看人在逋| 日韩欧美国产在线观看| 三级男女做爰猛烈吃奶摸视频| 香蕉av资源在线| aaaaa片日本免费| 欧美精品啪啪一区二区三区| 免费电影在线观看免费观看| 中文字幕精品亚洲无线码一区| 国产精品不卡视频一区二区| 少妇丰满av| 国产成人aa在线观看| 成年版毛片免费区| 九色成人免费人妻av| 美女高潮的动态| 亚洲第一区二区三区不卡| 国产黄色小视频在线观看| 免费无遮挡裸体视频| 九九热线精品视视频播放| 亚洲久久久久久中文字幕| 国产乱人视频| 嫩草影院新地址| 别揉我奶头 嗯啊视频| 国产一区二区三区av在线 | 全区人妻精品视频| 日韩强制内射视频| 99热这里只有是精品50| 午夜a级毛片| 国产亚洲欧美98| 欧美日韩黄片免| 午夜福利在线观看吧| 窝窝影院91人妻| 色吧在线观看| 精品午夜福利视频在线观看一区| 精品人妻偷拍中文字幕| 18禁裸乳无遮挡免费网站照片| 欧美激情国产日韩精品一区| 99热只有精品国产| 最新在线观看一区二区三区| 一个人看的www免费观看视频| 九九热线精品视视频播放| 老女人水多毛片| 国产午夜精品久久久久久一区二区三区 | 天天一区二区日本电影三级| 亚洲熟妇中文字幕五十中出| 亚洲精品乱码久久久v下载方式| 亚洲精品一区av在线观看| 最近中文字幕高清免费大全6 | 女生性感内裤真人,穿戴方法视频| 日韩一区二区视频免费看| 久久精品综合一区二区三区| 午夜日韩欧美国产| 成人特级av手机在线观看| 欧美高清成人免费视频www| 国产一区二区亚洲精品在线观看| 午夜免费男女啪啪视频观看 | 一级av片app| 精品久久久久久久久亚洲 | 丰满的人妻完整版| 精品99又大又爽又粗少妇毛片 | 99久久精品一区二区三区| 丰满乱子伦码专区| 欧美日本视频| 国产精品女同一区二区软件 | www.www免费av| 国产午夜福利久久久久久| 亚洲欧美清纯卡通| 亚洲成人免费电影在线观看| 真人一进一出gif抽搐免费| 午夜福利高清视频| 美女高潮喷水抽搐中文字幕| 精品久久久久久久久久久久久| 国产精品国产三级国产av玫瑰| 老女人水多毛片| 波多野结衣高清作品| av专区在线播放| 综合色av麻豆| 免费一级毛片在线播放高清视频| 欧美日韩中文字幕国产精品一区二区三区| 国产欧美日韩精品一区二区| 乱人视频在线观看| 国产精品不卡视频一区二区| 最近中文字幕高清免费大全6 | 91久久精品国产一区二区三区| 中文字幕av在线有码专区| 国产精品女同一区二区软件 | 真人一进一出gif抽搐免费| 国产极品精品免费视频能看的| 夜夜爽天天搞| netflix在线观看网站| 国产免费一级a男人的天堂| 日韩中文字幕欧美一区二区| 亚洲熟妇中文字幕五十中出| 又爽又黄无遮挡网站| 国产高潮美女av| 日本免费a在线| 深爱激情五月婷婷| 成人美女网站在线观看视频| 久久久成人免费电影| 国产中年淑女户外野战色| 三级国产精品欧美在线观看| 国产精品久久久久久av不卡| 欧美+日韩+精品| 日本爱情动作片www.在线观看 | 成人av一区二区三区在线看| 精品一区二区三区视频在线观看免费| 国产一区二区亚洲精品在线观看| 亚洲av成人精品一区久久| 亚洲内射少妇av| 日日摸夜夜添夜夜添av毛片 | 三级男女做爰猛烈吃奶摸视频| 久久九九热精品免费| 成人国产一区最新在线观看| 精品日产1卡2卡| 91麻豆精品激情在线观看国产| 联通29元200g的流量卡| or卡值多少钱| 熟妇人妻久久中文字幕3abv| www.www免费av| 国产精品综合久久久久久久免费| 国产日本99.免费观看| 午夜福利欧美成人| 亚洲av成人精品一区久久| 欧美日韩中文字幕国产精品一区二区三区| 两性午夜刺激爽爽歪歪视频在线观看| 成人无遮挡网站| 亚洲一区二区三区色噜噜| 免费在线观看成人毛片| 热99在线观看视频| 真实男女啪啪啪动态图| 嫩草影院精品99| 天天一区二区日本电影三级| 国产精华一区二区三区| 男人舔奶头视频| 亚洲av不卡在线观看| 在线观看免费视频日本深夜| bbb黄色大片| 搡老岳熟女国产| 午夜久久久久精精品| 久久6这里有精品| 中国美白少妇内射xxxbb| av视频在线观看入口| 一级黄色大片毛片| 别揉我奶头~嗯~啊~动态视频| 村上凉子中文字幕在线| 欧美高清性xxxxhd video| 欧美精品国产亚洲| 久久精品国产亚洲av涩爱 | 69人妻影院| 中文亚洲av片在线观看爽| 无人区码免费观看不卡| 久久亚洲精品不卡| 日日摸夜夜添夜夜添小说| or卡值多少钱| 在线观看66精品国产| 精品无人区乱码1区二区| avwww免费| 欧洲精品卡2卡3卡4卡5卡区| 99在线人妻在线中文字幕| 欧美绝顶高潮抽搐喷水| 国产亚洲av嫩草精品影院| 免费在线观看影片大全网站| 亚洲五月天丁香| av福利片在线观看| 一本久久中文字幕| 国产精品98久久久久久宅男小说| 亚洲aⅴ乱码一区二区在线播放| 又黄又爽又免费观看的视频| 午夜亚洲福利在线播放| 久久精品国产亚洲av涩爱 | 看十八女毛片水多多多| 亚洲aⅴ乱码一区二区在线播放| 人妻制服诱惑在线中文字幕| 日本a在线网址| 看十八女毛片水多多多| 久久亚洲真实| 22中文网久久字幕| 欧洲精品卡2卡3卡4卡5卡区| 亚洲综合色惰| 久久久久久久亚洲中文字幕| 99热只有精品国产| 久久久久久久午夜电影| 久久精品国产亚洲av涩爱 | 三级国产精品欧美在线观看| 亚洲精品久久国产高清桃花| 欧美三级亚洲精品| 成人av在线播放网站| 人人妻,人人澡人人爽秒播| 桃色一区二区三区在线观看| 国产男靠女视频免费网站| 麻豆精品久久久久久蜜桃| 亚洲成人中文字幕在线播放| 一卡2卡三卡四卡精品乱码亚洲| 国产伦精品一区二区三区视频9| 国产大屁股一区二区在线视频| 久久人人爽人人爽人人片va| 大又大粗又爽又黄少妇毛片口| 国国产精品蜜臀av免费| 国产欧美日韩精品一区二区| 18禁在线播放成人免费| 国产乱人伦免费视频| 国产成人影院久久av| 国内少妇人妻偷人精品xxx网站| 美女高潮的动态| 成人国产麻豆网| 欧洲精品卡2卡3卡4卡5卡区| 日日撸夜夜添| 精品久久久噜噜| 欧美日韩中文字幕国产精品一区二区三区| 看黄色毛片网站| 一个人免费在线观看电影| 欧美日韩瑟瑟在线播放| 午夜福利在线观看吧| 国产精品一区二区性色av| 亚洲人成伊人成综合网2020| 亚洲美女黄片视频| 亚洲avbb在线观看| 美女高潮喷水抽搐中文字幕| 日韩在线高清观看一区二区三区 | 国产在视频线在精品| 天堂动漫精品| 亚洲人与动物交配视频| 欧美+日韩+精品| 啪啪无遮挡十八禁网站| 全区人妻精品视频| 别揉我奶头~嗯~啊~动态视频| 神马国产精品三级电影在线观看| 免费在线观看成人毛片| 五月伊人婷婷丁香| 中文字幕人妻熟人妻熟丝袜美| 久久亚洲精品不卡| 午夜免费男女啪啪视频观看 | 国产又黄又爽又无遮挡在线| 天美传媒精品一区二区| 久久精品91蜜桃| 欧美成人免费av一区二区三区| 成年女人永久免费观看视频| 看十八女毛片水多多多| 国产日本99.免费观看| 深夜精品福利| 欧美不卡视频在线免费观看| 一级黄片播放器| 午夜福利欧美成人| 日韩欧美在线乱码| 亚洲四区av| 国产三级中文精品| 日本一本二区三区精品| 丝袜美腿在线中文| 91午夜精品亚洲一区二区三区 | 中文字幕熟女人妻在线| 国产视频一区二区在线看| 亚洲精品456在线播放app | 婷婷亚洲欧美| 国内精品久久久久久久电影| 高清日韩中文字幕在线| 色5月婷婷丁香| 在线免费十八禁| 搡女人真爽免费视频火全软件 | 在线观看免费视频日本深夜| 免费看日本二区| 琪琪午夜伦伦电影理论片6080| 国产视频一区二区在线看| 国产v大片淫在线免费观看| 色综合站精品国产| 久久精品91蜜桃| 精品久久久久久成人av| av在线天堂中文字幕| 国产高潮美女av| 一本精品99久久精品77| 两个人视频免费观看高清| 久久欧美精品欧美久久欧美| 亚洲在线观看片| 欧美一区二区亚洲| 动漫黄色视频在线观看| 亚洲不卡免费看| 欧美日韩乱码在线|